Although the TREAT registry has shown systemic infliximab to be safe in the long term, there is concern regarding infectious as well as neoplastic complications.

• 虽然，TREAT登记处已经指出，从长期观察来看，全身性应用英夫利昔单抗是安全的，但要关注发生肿瘤以及感染性并发症。